United Kingdom's contribution to European research output in biomedical sciences: 2008–2017

Background: On 31 January 2020, the United Kingdom (UK) formally left the European Union (EU). Only a short transition period, until 31 December 2020, is available to negotiate collaborations for research in biomedical sciences and health care. Within the European scientific community, two opinions...

Full description

Bibliographic Details
Published in:European Science Editing
Main Authors: Tan, Raoul, Sijbrands, Eric
Format: Article in Journal/Newspaper
Language:unknown
Published: European Association of Science Editors (EASE) 2020
Subjects:
Online Access:https://zenodo.org/record/3861939
https://doi.org/10.3897/ese.2020.e51112
id ftzenodo:oai:zenodo.org:3861939
record_format openpolar
spelling ftzenodo:oai:zenodo.org:3861939 2023-05-15T16:11:02+02:00 United Kingdom's contribution to European research output in biomedical sciences: 2008–2017 Tan, Raoul Sijbrands, Eric 2020-05-20 https://zenodo.org/record/3861939 https://doi.org/10.3897/ese.2020.e51112 unknown European Association of Science Editors (EASE) https://zenodo.org/record/3861939 https://doi.org/10.3897/ese.2020.e51112 oai:zenodo.org:3861939 info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by/4.0/legalcode European Science Editing 46 e51112 Biomedical research in EU Brexit research collaborations quantifying research contributions info:eu-repo/semantics/article publication-article 2020 ftzenodo https://doi.org/10.3897/ese.2020.e51112 2023-03-11T00:14:57Z Background: On 31 January 2020, the United Kingdom (UK) formally left the European Union (EU). Only a short transition period, until 31 December 2020, is available to negotiate collaborations for research in biomedical sciences and health care. Within the European scientific community, two opinions are common: 1) Brexit is an opportunity to obtain more funding at the expense of the departing British; and 2) UK colleagues should continue to collaborate in EU scientific efforts, including Horizon Europe and Erasmus+. To provide evidence for more informed negotiations, we sought to determine the contribution of the UK to EU’s research in biomedical sciences.Methods: We performed a macro level scientometric analysis to estimate the contribution of the UK and EU member states, including those associated with EU-funding (EU+) namely Albania, Armenia, Bosnia-Herzegovina, Faroe Islands, Georgia, Iceland, Israel, Macedonia, Moldova, Montenegro, Norway, Serbia, Switzerland, Tunisia, Turkey, and Ukraine, to preclinical, clinical and health sciences. We searched the Web of Science database to count the total number of scientific publications and the top 1% most cited publications in the world between 2008 and 2017, calculated the performance efficiency by dividing the top 1% by the total number, and calculated the odds ratios to create a ranking of performance efficiency. We then compared the contribution of the UK to all the EU+ -based publications and the top 1% to the contributions of the ten EU member states with the largest biomedical research output and also compared the respective contributions to EU+ publications that resulted from collaborations with other regions in the world.Results: We found 2,991,016 biomedical publications from EU+ during 2008–2017, of which 19,019 (0.64%) were in the world’s top 1% of the most cited publications. The UK produced 665,467 (22.3%) of these publications and had over two and a half times more top 1% most cited publications than the EU+ (odds ratio 2.79, 95% CI 2.71–2.88, p< ... Article in Journal/Newspaper Faroe Islands Iceland Zenodo Faroe Islands Norway European Science Editing 46
institution Open Polar
collection Zenodo
op_collection_id ftzenodo
language unknown
topic Biomedical research in EU
Brexit
research collaborations
quantifying research contributions
spellingShingle Biomedical research in EU
Brexit
research collaborations
quantifying research contributions
Tan, Raoul
Sijbrands, Eric
United Kingdom's contribution to European research output in biomedical sciences: 2008–2017
topic_facet Biomedical research in EU
Brexit
research collaborations
quantifying research contributions
description Background: On 31 January 2020, the United Kingdom (UK) formally left the European Union (EU). Only a short transition period, until 31 December 2020, is available to negotiate collaborations for research in biomedical sciences and health care. Within the European scientific community, two opinions are common: 1) Brexit is an opportunity to obtain more funding at the expense of the departing British; and 2) UK colleagues should continue to collaborate in EU scientific efforts, including Horizon Europe and Erasmus+. To provide evidence for more informed negotiations, we sought to determine the contribution of the UK to EU’s research in biomedical sciences.Methods: We performed a macro level scientometric analysis to estimate the contribution of the UK and EU member states, including those associated with EU-funding (EU+) namely Albania, Armenia, Bosnia-Herzegovina, Faroe Islands, Georgia, Iceland, Israel, Macedonia, Moldova, Montenegro, Norway, Serbia, Switzerland, Tunisia, Turkey, and Ukraine, to preclinical, clinical and health sciences. We searched the Web of Science database to count the total number of scientific publications and the top 1% most cited publications in the world between 2008 and 2017, calculated the performance efficiency by dividing the top 1% by the total number, and calculated the odds ratios to create a ranking of performance efficiency. We then compared the contribution of the UK to all the EU+ -based publications and the top 1% to the contributions of the ten EU member states with the largest biomedical research output and also compared the respective contributions to EU+ publications that resulted from collaborations with other regions in the world.Results: We found 2,991,016 biomedical publications from EU+ during 2008–2017, of which 19,019 (0.64%) were in the world’s top 1% of the most cited publications. The UK produced 665,467 (22.3%) of these publications and had over two and a half times more top 1% most cited publications than the EU+ (odds ratio 2.79, 95% CI 2.71–2.88, p< ...
format Article in Journal/Newspaper
author Tan, Raoul
Sijbrands, Eric
author_facet Tan, Raoul
Sijbrands, Eric
author_sort Tan, Raoul
title United Kingdom's contribution to European research output in biomedical sciences: 2008–2017
title_short United Kingdom's contribution to European research output in biomedical sciences: 2008–2017
title_full United Kingdom's contribution to European research output in biomedical sciences: 2008–2017
title_fullStr United Kingdom's contribution to European research output in biomedical sciences: 2008–2017
title_full_unstemmed United Kingdom's contribution to European research output in biomedical sciences: 2008–2017
title_sort united kingdom's contribution to european research output in biomedical sciences: 2008–2017
publisher European Association of Science Editors (EASE)
publishDate 2020
url https://zenodo.org/record/3861939
https://doi.org/10.3897/ese.2020.e51112
geographic Faroe Islands
Norway
geographic_facet Faroe Islands
Norway
genre Faroe Islands
Iceland
genre_facet Faroe Islands
Iceland
op_source European Science Editing 46 e51112
op_relation https://zenodo.org/record/3861939
https://doi.org/10.3897/ese.2020.e51112
oai:zenodo.org:3861939
op_rights info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by/4.0/legalcode
op_doi https://doi.org/10.3897/ese.2020.e51112
container_title European Science Editing
container_volume 46
_version_ 1765996155877982208